My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Actas Urológicas Españolas
Print version ISSN 0210-4806
Abstract
GARCIA GONZALEZ, Jorge et al. Use of M-VAC in the adjuvant treatment of sarcomatoid carcinoma of the bladder. Actas Urol Esp [online]. 2009, vol.33, n.4, pp.447-449. ISSN 0210-4806.
Sarcomatoid bladder carcinoma is a high-grade neoplasm and accounts for approximately 0,3% of all bladder malignancies. Sarcomatoid carcinoma originates from transitional cells of the bladder. Sarcomatoid carcinoma is charactericed by a epithelial component and a sarcomatoid component, consisting of spindle cells, that is only epithelial marker-positive. We report a 26 year-old woman diagnosed of stage III sarcomatoid bladder carcinoma (T3aN0M0) treated with partial cistectomy followed by 4 cycles of adjuvant chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.
Keywords : Bladder carcinoma; Sarcomatoid carcinoma; Immunohistochemestry; Cytokeratins; Chemotherapy.